Ketogenic diet promotes tumor ferroptosis but induces relative corticosterone deficiency that accelerates cachexia-Reference-Cited by-同舟云学术

Ketogenic diet promotes tumor ferroptosis but induces relative corticosterone deficiency that accelerates cachexia

Published:2023-07 Issue:7 Volume:35 Page:1147-1162.e7
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Ferrer Miriam,Mourikis Nicholas,Davidson Emma E.,Kleeman Sam O.,Zaccaria Marta,Habel Jill,Rubino Rachel,Gao Qing,Flint Thomas R.,Young Lisa,Connell Claire M.,Lukey Michael J.,Goncalves Marcus D.,White Eileen P.,Venkitaraman Ashok R.,Janowitz Tobias^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference63 articles.

1. The metabolism of carcinoma cells 1;Warburg;J. Cancer Res.,1925

2. Prevalence, incidence and clinical impact of cachexia: facts and numbers—update 2014;von Haehling;J. Cachexia Sarcopenia Muscle,2014

3. Cachexia: a systemic consequence of progressive, unresolved disease;Ferrer;Cell,2023

4. The development of tumours under a ketogenic diet in association with the novel tumour marker TKTL1: a case series in general practice;Jansen;Oncol. Lett.,2016

5. Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides;Otto;BMC Cancer,2008

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The P2X7 receptor mediates NADPH transport across the plasma membrane;Biochemical and Biophysical Research Communications;2024-12

2. Take the bull by the horns and tackle the potential downsides of the ketogenic diet;Nutrition;2024-09

3. Immunometabolism of ferroptosis in the tumor microenvironment;Frontiers in Oncology;2024-08-12

4. β‐Hydroxybutyrate enhances chondrocyte mitophagy and reduces cartilage degeneration in osteoarthritis via the HCAR2/AMPK/PINK1/Parkin pathway;Aging Cell;2024-08-09

5. Ketogenesis attenuated KLF5 disrupts iron homeostasis via LIF to confer oxaliplatin vulnerability in colorectal cancer;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-08